A carregar...

Aberrant Methylation of the X-linked Ribosomal S6 Kinase RPS6KA6 (RSK4) in Endometrial Cancers

PURPOSE: Effective treatments for advanced endometrial cancer are lacking. Novel therapies that target specific pathways hold promise for better treatment outcomes with less toxicity. Mutation activation of the FGFR2/RAS/ERK pathway is important in endometrial tumorigenesis. RPS6KA6 (Rsk4) is a puta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dewdney, Summer B., Rimel, BJ, Thaker, Premal H., Thompson, Dominic M., Schmidt, Amy, Huettner, Phyllis, Mutch, David G., Gao, Feng, Goodfellow, Paul J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3242504/
https://ncbi.nlm.nih.gov/pubmed/21372219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-2668
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!